https://www.databridgemarketresearch.com/reports/global-application-specific-integrated-circuit-asic-market #marketscope #marketsize #markettrend #marketshare #marketdemand #marketforecast

https://www.databridgemarketresearch.com/reports/north-america-hollow-core-insulator-market #marketscope #marketsize #markettrend #marketshare #marketdemand #marketforecast

https://www.databridgemarketresearch.com/reports/global-aldose-reductase-inhibitor-market #marketscope #marketsize #markettrends #marketanalysis #marketshare #marketforecast

Dental 3D Printing market Professional Survey Report by 2035 The “Dental 3D Printing Market, 2023-2035” report features an extensive study of the current market landscape and future potential of the dental 3D printing market over the next decade. Key Inclusions  A general overview of dental 3D printing, highlighting details on technologies used in dental 3D printers and applications of 3D printing in the dental industry. It also presents information on the advantages and limitations associated with dental 3D printing. Additionally, it features a discussion on the future prospects within this domain.  A detailed assessment of the overall market landscape of around 230 dental 3D printers, based on several relevant parameters, such as type of product(s) printed (crowns / bridges / dentures, working models, surgical guides, aligners/ hawley retainers/ brackets, implants, gingival masks and others), application area(s) (prosthodontics, orthodontics and dental implants), type of printing technology (digital light processing (DLP), stereolithography (SLA), liquid crystal display (LCD), selective laser melting (SLM), radio-frequency identification (RFID), direct metal laser sintering (DMLS), masked stereolithography (MSLA), carbon digital light synthesis (Carbon DLS), polyjet, melted extrusion modelling (MEM), powder bed fusion, subpixel micro scan (SMS), multijet and others), type of printing process (vat photopolymerization, powder bed fusion, polyjet, material extrusion and others), type of printing material(s) (resins, polymers, metals, ceramics and others / unspecified), printer wavelength (upto 405 nm and above 405 nm), type of connectivity (ethernet, USB, Wi-Fi, cloud and others / undisclosed), printing speed (below 50 mm/hour, 50-100 mm/hour, 101-150 mm/hour, 151-200 mm/hour, 201-25 mm/hour, 251-300 mm/hour and others), layer thickness of printed products (below 50 µm, 50-100 µm, 101-150 µm, 151-200 µm and above 200 µm), printer resolution (below 50 µm, 50-100 µm, above 100 µm and others) and printer price (below USD 10,000, USD 10,000-50,000, USD 50,000-100,000, above USD 100,000 and undisclosed). In addition, it provides details on the dental 3D printer manufacturers, along with analysis based on their year of establishment, company size, location of headquarters and leading players (in terms of number of dental 3D printers offered).  A product competitiveness analysis of the dental 3D printers, based on supplier power (in terms of the experience of the developer) and product competitiveness (in terms of number of products printed, application area, printing process, type of printing material, wavelength, type of connectivity, layer thickness of printed products, resolution and printer price).  Elaborate profiles of the prominent players (shortlisted based on proprietary scoring criteria) engaged in dental 3D printing domain. Each company profile features a brief overview of the company, details related to its dental 3D printer portfolio, recent developments and an informed future outlook.  An analysis of partnerships that have been inked by dental 3D printer manufacturers engaged in this domain, since 2018, covering instances of product integration agreements, distribution agreements, technology utilization agreements, acquisitions and mergers, commercialization agreements, service alliances, product development agreements, technology integration agreements, research and development agreements and others. Further, the partnership activity in this domain has been analyzed based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships) and regional distribution of collaborations.  An in-depth analysis of the patents that have been filed / granted related to dental 3D printing, since 2019, taking into consideration several relevant parameters, such as type of patent, publication year, application year, geographical location, CPC symbols, type of applicant, patent age and leading players (in terms of number of patents filed / granted). It also features a patent benchmarking analysis and a detailed patent characteristics and patent valuation analysis.  A Bowman's strategy clock framework to understand the pricing strategy of the dental 3D printer offered by a company, along with its competitive position in the market. In addition, it presents the equation devised to calculate the likely price of dental 3D printers based upon their characteristics. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Type of Printing Technology  VAT Polymerization Technology  Powder Bed Fusion Technology  Polyjet Technology  Metal Extrusion Technology  Other Technologies  Application Area  Prosthodontics  Orthodontics  Dental Implants  Other Applications  Type of Printing Material  Resins  Plastics  Metals  Metals  Other Material  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World Key Questions Answered  How is 3D printing used in the dental industry?  How many dental 3D printers are currently available in the market?  Which 3D printers are best for dentistry?  What is the growth rate of the dental 3D printing market?  Which region captures the largest share of the dental 3D printing market?  Which printing technology is widely used in the dental 3D printers?  Which application area currently holds the largest share in the dental 3D printing market?  What are the partnerships and collaborations trend in the dental 3D printing domain?  How many patents have been filed / granted related to dental 3D printing in the recent years? Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html You may also be interested in the following titles: DNA Encoded Libraries Quantum Computing in Drug Discovery Services Market You may also like to learn what our experts are sharing in Roots educational series: T-cell Immunotherapies: The Future of Modern Cancer Treatments Monkeypox: Disease Overview, Transmission and Diagnosis About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Dental3DPrintingmarket #Dental3DPrintingmarketsize #Dental3dPrinterManufacturers #3DDentalPrinterManufacturers #Dental3DPrinterManufacturersforDentalImplants

Bacteriophage therapeutics market Research Report by 2022, Forecast till 2035 The ‘Bacteriophage Therapeutics Market, 2022-2035’ report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics, over the coming few years Key Inclusions  A summary of the key insights from the bacteriophage therapeutics market. It offers a high-level view on the current state of the market and its likely evolution in the mid to long term.  A general overview of the historical evolution of bacteriophages and their biology. It also includes a detailed discussion on applications of bacteriophage therapy. The chapter concludes with a discussion on the various advantages and limitations associated with the bacteriophage therapy.  A detailed overview of the overall market landscape of bacteriophage therapeutics, including information on their current status of development (marketed, clinical, preclinical and discovery), key therapeutic areas (infectious diseases, oncological disorders, and other disorders), type of bacterial strain (Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Salmonella, Streptococcus, Acinetobacter baumannii and others), target disease indication (lung infection, bone infection, urinary tract infection, gastrointestinal infection, bacterial infection, blood infection, other disorders, and multiple infections), type of therapy (monotherapy, combination therapy, and both), route of administration (oral route, topical route, rectal route and intravenous route), and information on bacteriophage related technologies.  An overview of the current status of the market with respect to the players engaged in the manufacturing of bacteriophage therapeutics, featuring information on the year of establishment, company size, location of headquarters, and leading developers.  Elaborate profiles of the prominent players engaged in the development of bacteriophage therapeutics (shortlisted based on the number of drugs progressed to advanced phases of development). Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, and a section on recent developments and an informed future outlook.  An in-depth analysis of completed, ongoing and planned clinical studies, based on several relevant parameters, such as trial registration year, trial phase, enrolled patient population, study design, type of sponsor / collaborator, most active players (in terms of number of registered trials), registered trials, and geographical region (by number of registered trials and number of enrolled patient population).  An in-depth analysis of the various patents that have been filed / granted related to bacteriophage therapeutics. It includes information on key parameters, such as type of patent (granted patents, patent applications and others), publication year, application year, number of granted patents and patent applications, geographical distribution, Cooperative Patent Classification (CPC) symbols, and type of applicant. It also highlights the leading industry and non-industry players and individual assignees (in terms of number of patents filed / granted).  An in-depth analysis of various publications for bacteriophage therapeutics, based on several relevant parameters, such as year of publication, type of article, popular keywords, most popular publishers (in terms of number of publications), key journals (in terms of number of articles published and journal impact factor). It also highlights benchmarking of the publications to develop more insightful opinions on the recent trends related to research and development in this area.  A detailed study of the various grants that have been awarded to research institutes engaged in projects related to bacteriophage therapeutics, since 2017, highlighting various important parameters, such as year of award, amount awarded, funding institute, support period, grant type, purpose of grant, focus area, type of recipient organization, and leading recipient organizations.  An in-depth analysis of the investments made, including grants, venture capital financing, initial public offering, secondary offering, private placement, equity and debt funding, at various stages of development, in companies that are focused on developing bacteriophage therapeutics.  A detailed study of the recent collaborations and partnership established in this domain since 2017, including the details of deals that were / are focused on the development of bacteriophage therapeutics, which were analyzed based on several parameters such as year of partnership, type of partnership (research and development agreement, product development agreement, licensing agreement, merger / acquisition, commercialization agreement, manufacturing agreement, clinical trial agreement, supply agreement, distribution agreement and other agreement), therapeutic area (infectious diseases, hepatological disorders, chronic inflammatory disorders, skin disorders and women’s health), application areas (human health, animal health, diagnostic test, aquaculture, food safety, food safety and environment protection and livestock farming), and regional distribution of partnerships.  An analysis of the various start-ups engaged in the development of bacteriophage therapeutics, based on relevant parameters, such as pipeline strength, pipeline maturity, indication diversity, number of patents, financial support and partnership activity The financial opportunity within the bacteriophage therapy market has been analyzed across the following segments:  Type of Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The report features inputs from eminent industry stakeholders, according to whom upcoming generations of bacteriophage therapeutics are likely to garner significant interest among therapy developers and end users alike. The report includes detailed transcripts of discussions held with the following experts:  Antoine Culot (Chief Executive Officer, Rime Bioinformatics)  Mathieu Medina (Project Leader, Hospices Civils De Lyon)  Iddo Weiner (Senior Director, Head of Data-Science, BiomX)  Mohammadreza Azizkhani (Independent Consultant) Key Questions Answered  Which bacteriophage therapeutics candidates are currently under clinical stage of development pipeline?  Who are the leading players engaged in the development of bacteriophage therapeutics?  Which geographies are the most active in conducting clinical trials related to bacteriophage therapeutics?  What is the focus of various publications related to bacteriophage therapeutics?  Which partnership models are commonly adopted by industry and non-industry stakeholders?  What are the investment trends in the industry?  What are the different initiatives undertaken by start-ups for the development of bacteriophage therapeutics in the recent past?  How is the current and future market opportunity likely to be distributed across key market segments? For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Lab Automation Market Cannabis Testing Market You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Bacteriophagetherapeuticsmarket #Bacteriophagetherapeuticsmarketsize #bacteriophage #phage #bacteriophagetherapy